| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 健康相关产品(元) | 548,925,958.38 | 1,132,395,469.74 | 633,840,588.55 |
| 药品(元) | 1,387,592,465.57 | 2,849,296,915.72 | 1,675,837,322.32 |
| 其他(元) | 38,573,052.46 | 93,200,542.24 | 54,654,887.92 |
| 营业成本(元) | |||
| 健康相关产品(元) | 358,260,561.73 | 722,050,935.59 | 390,907,116.15 |
| 药品(元) | 888,649,709.39 | 1,790,576,659.83 | 1,055,334,210.67 |
| 其他(元) | 5,442,589.40 | 16,253,153.42 | 11,189,837.76 |
| 毛利(元) | |||
| 健康相关产品(元) | 190,665,396.65 | 410,344,534.15 | 242,933,472.40 |
| 药品(元) | 498,942,756.18 | 1,058,720,255.89 | 620,503,111.65 |
| 其他(元) | 33,130,463.06 | 76,947,388.82 | 43,465,050.16 |
| 毛利率(%) | |||
| 健康相关产品(%) | 34.73 | 36.24 | 38.33 |
| 药品(%) | 35.96 | 37.16 | 37.03 |
| 其他(%) | 85.89 | 82.56 | 79.53 |
| 收入构成(%) | |||
| 健康相关产品(%) | 27.79 | 27.79 | 26.81 |
| 药品(%) | 70.25 | 69.92 | 70.88 |
| 其他(%) | 1.95 | 2.29 | 2.31 |
| 毛利构成(%) | |||
| 健康相关产品(%) | 26.38 | 26.54 | 26.79 |
| 药品(%) | 69.04 | 68.48 | 68.42 |
| 其他(%) | 4.58 | 4.98 | 4.79 |